Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study. - Heersche N; Lanser DAC; Oomen-de Hoop E; Içli A; de Bruijn P; Paats MS; van Rossum EFC; Koolen SLW; van Schaik RHN; Dingemans AC; Veerman GDM; Mathijssen RHJ (Cancer communications (London, England), 2025)